TECH
Income statement / Annual
Last year (2024), Bio-Techne Corporation's total revenue was $1.16 B,
an increase of 1.97% from the previous year.
In 2024, Bio-Techne Corporation's net income was $168.11 M.
See Bio-Techne Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$1.16 B
|
$1.14 B
|
$1.11 B
|
$931.03 M
|
$738.69 M
|
$714.01 M
|
$642.99 M
|
$563.00 M
|
$499.02 M
|
$452.25 M
|
| Cost of Revenue |
$385.99 M |
$366.89 M |
$349.10 M |
$298.18 M |
$255.50 M |
$240.52 M |
$210.85 M |
$188.46 M |
$162.36 M |
$144.97 M |
| Gross Profit |
$773.07 M |
$769.82 M |
$756.50 M |
$632.85 M |
$483.19 M |
$473.49 M |
$432.14 M |
$374.54 M |
$336.66 M |
$307.28 M |
| Gross Profit Ratio |
0.67 |
0.68 |
0.68 |
0.68 |
0.65 |
0.66 |
0.67 |
0.67 |
0.67 |
0.68 |
| Research and Development
Expenses |
$96.66 M
|
$92.49 M
|
$87.14 M
|
$70.60 M
|
$65.19 M
|
$62.41 M
|
$55.33 M
|
$53.51 M
|
$45.19 M
|
$40.85 M
|
| General & Administrative
Expenses |
$396.83 M
|
$352.44 M
|
$339.00 M
|
$289.92 M
|
$240.88 M
|
$236.87 M
|
$240.64 M
|
$153.33 M
|
$140.88 M
|
$119.40 M
|
| Selling & Marketing
Expenses |
$26.54 M
|
$25.94 M
|
$33.77 M
|
$35.03 M
|
$19.70 M
|
$27.49 M
|
$0.00
|
$45.92 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$423.36 M
|
$378.38 M
|
$372.77 M
|
$324.95 M
|
$260.58 M
|
$264.36 M
|
$240.64 M
|
$199.24 M
|
$140.88 M
|
$119.40 M
|
| Other Expenses |
$330,000.00 |
$39.72 M |
$4.80 M |
-$89.12 M |
$119.06 M |
-$34.70 M |
-$10.23 M |
-$8.56 M |
-$3.11 M |
$7.14 M |
| Operating Expenses |
$520.03 M |
$470.87 M |
$459.91 M |
$395.55 M |
$325.78 M |
$326.77 M |
$295.97 M |
$252.76 M |
$186.07 M |
$160.25 M |
| Cost And Expenses |
$906.01 M |
$837.76 M |
$809.01 M |
$693.74 M |
$581.27 M |
$567.29 M |
$506.82 M |
$441.22 M |
$348.43 M |
$305.22 M |
| Interest Income |
$3.32 M |
$3.41 M |
$794,000.00 |
$473,000.00 |
$605,000.00 |
$569,000.00 |
$409,000.00 |
$304,000.00 |
$249,000.00 |
$634,000.00 |
| Interest Expense |
$15.74 M |
-$11.22 M |
$11.31 M |
$13.95 M |
$19.20 M |
$21.71 M |
$10.19 M |
$7.36 M |
$1.75 M |
$1.54 M |
| Depreciation &
Amortization |
$111.71 M
|
$107.24 M
|
$101.07 M
|
$87.75 M
|
$82.74 M
|
$78.17 M
|
$64.46 M
|
$60.04 M
|
$42.76 M
|
$37.23 M
|
| EBITDA |
$364.76 M
|
$406.18 M
|
$397.66 M
|
$237.30 M
|
$157.42 M
|
$146.72 M
|
$136.18 M
|
$121.78 M
|
$150.59 M
|
$147.02 M
|
| EBITDA Ratio |
0.31 |
0.36 |
0.36 |
0.25 |
0.21 |
0.21 |
0.21 |
0.22 |
0.3 |
0.33 |
| Operating Income Ratio
|
0.22
|
0.26
|
0.27
|
0.16
|
0.1
|
0.18
|
0.21
|
0.22
|
0.3
|
0.33
|
| Total Other
Income/Expenses Net |
-$67.36 M
|
$39.72 M
|
$4.80 M
|
-$1.37 M
|
$201.80 M
|
$43.47 M
|
-$10.23 M
|
-$8.56 M
|
-$3.11 M
|
$7.14 M
|
| Income Before Tax |
$185.69 M |
$338.66 M |
$301.39 M |
$148.18 M |
$276.48 M |
$112.02 M |
$125.95 M |
$113.16 M |
$147.48 M |
$154.16 M |
| Income Before Tax Ratio
|
0.16
|
0.3
|
0.27
|
0.16
|
0.37
|
0.16
|
0.2
|
0.2
|
0.3
|
0.34
|
| Income Tax Expense |
$17.58 M |
$53.22 M |
$38.29 M |
$8.59 M |
$47.18 M |
$15.94 M |
$602,000.00 |
$35.88 M |
$43.01 M |
$46.43 M |
| Net Income |
$168.11 M |
$285.26 M |
$272.05 M |
$140.41 M |
$229.30 M |
$96.07 M |
$125.35 M |
$77.29 M |
$104.48 M |
$107.74 M |
| Net Income Ratio |
0.15 |
0.25 |
0.25 |
0.15 |
0.31 |
0.13 |
0.19 |
0.14 |
0.21 |
0.24 |
| EPS |
1.07 |
1.81 |
1.73 |
0.91 |
1.5 |
0.64 |
0.84 |
0.52 |
0.7 |
0.73 |
| EPS Diluted |
1.05 |
1.76 |
1.66 |
0.87 |
1.45 |
0.62 |
0.82 |
0.52 |
0.7 |
0.72 |
| Weighted Average Shares
Out |
$157.71 M
|
$157.18 M
|
$156.88 M
|
$154.99 M
|
$152.80 M
|
$151.12 M
|
$149.90 M
|
$149.25 M
|
$148.78 M
|
$148.38 M
|
| Weighted Average Shares
Out Diluted |
$160.77 M
|
$161.86 M
|
$164.12 M
|
$161.93 M
|
$157.60 M
|
$155.57 M
|
$152.22 M
|
$150.00 M
|
$149.30 M
|
$148.92 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
